Literature DB >> 26988430

Health-promoting and disease-preventive potential of Trianthema portulacastrum Linn. (Gadabani) -An Indian medicinal and dietary plant.

Jason Yamaki1,2, Kalyan C Nagulapalli Venkata3, Animesh Mandal4, Piyali Bhattacharyya5, Anupam Bishayee3.   

Abstract

It is estimated that 80% of the world population depends on traditional medicine for primary healthcare need. Trianthema portulacastrum Linn. (family: Aizoaceae) is a small perennial weed found in the Americas, Africa, India, and other regions of the world. This plant is used extensively in Indian traditional medicines and is also consumed as a vegetable throughout Asia for its perceived health benefits. Phytochemical analysis of T. portulacastrum reveals the presence of alkaloids, flavonoids, terpenoids, saponins, and phenolic compounds. Emerging studies demonstrate that crude extracts as well as bioactive phytoconstituents of T. portulacastrum exhibit potent antioxidant, anti-infective, analgesic, and anti-inflammatory activities. A growing number of in vitro and in vivo studies demonstrate various biological and pharmacological activities, including prevention and amelioration of hepatotoxicity, nephrotoxicity, hyperglycemia, hyperlipidemia, infectious diseases and cancer. This review aims to present and analyze available literature to understand the full potential of T. portulacastrum in health promotion and disease prevention. Current limitations and future directions of research on this medicinal and dietary plant are also critically discussed.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26988430     DOI: 10.1016/S2095-4964(16)60247-9

Source DB:  PubMed          Journal:  J Integr Med


  4 in total

1.  Ameliorative effect of biofabricated ZnO nanoparticles of Trianthema portulacastrum Linn. on dermal wounds via removal of oxidative stress and inflammation.

Authors:  Ekta Yadav; Deepika Singh; Pankajkumar Yadav; Amita Verma
Journal:  RSC Adv       Date:  2018-06-13       Impact factor: 4.036

2.  In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetes.

Authors:  Permal Deo; Erandi Hewawasam; Aris Karakoulakis; David J Claudie; Robert Nelson; Bradley S Simpson; Nicholas M Smith; Susan J Semple
Journal:  BMC Complement Altern Med       Date:  2016-11-04       Impact factor: 3.659

3.  Analgesic and anti-inflammatory potential of Lupeol isolated from Indian traditional medicinal plant Crateva adansonii screened through in vivo and in silico approaches.

Authors:  Thirumalaisamy Rathinavel; Subramanian Ammashi; Gnanendra Shanmugam
Journal:  J Genet Eng Biotechnol       Date:  2021-05-04

4.  An ethnobotanical survey of medicinal plants used by traditional healers for the treatment of cancer in Hammanskraal and Winterveld, Tshwane Metropolitan Municipality, South Africa.

Authors:  Idris O Raimi; Boikanyo G Kopaopa; Liziwe L Mugivhisa; Francis B Lewu; Stephen O Amoo; Joshua O Olowoyo
Journal:  Afr Health Sci       Date:  2021-12       Impact factor: 0.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.